Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

ECTRIMS 2024 – Oral Presentations

Multiple Sclerosis Journal

Impact Factor: 4.1 / 5-Year Impact Factor: 4.9

Journal Homepage Submission guidelines

Restricted access

Abstract

First published online September, 2024

ECTRIMS 2024 – Oral Presentations

Volume 30, Issue 3_suppl

https://doi.org/10.1177/13524585241269218

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

Advanced MRI measures like DTI or fMRI should be outcome measures in future clinical trials – NO

Restricted access

A Parallel-Group Comparison of Budesonide and Beclomethasone Dipropionate for the Treatment of Perennial Allergic Rhinitis in Adults

Restricted access

Methylprednisolone treatment in multiple sclerosis: effect of treatment,pharmacokinetics,future

Restricted access

A Double-Blind Study Comparing Oleum Horwathiensis with Placebo in the Treatment of Psoriasis